Cerebral hyperfusion syndrome (CHS) is a rare complication with high mortality in patients with carotid stenosis after carotid endarterectomy, carotid stenting or intracranial arterial stenting. This review summarizes the definition, risk factors, pathogenesis, monitoring methods, prevention and treatment of CHS in recent years, providing clinical insights for future prevention and treatment of CHS.